Xlife Sciences AG (SIX: XLS)

https://www.xlifesciences.ch

LinkedIn: https://www.linkedin.com/company/xlifesciences/

Xlife Sciences AG is a Swiss company focused on investing in promising technologies in the life science industry. Xlife Sciences AG is building the bridge from research and development to healthcare markets by supporting researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. Together with industrial partners or universities, Xlife Sciences AG leads projects through the proof-of-concept phase after an invention disclosure or start-up. Subsequently, the firm focuses on out-licensing or selling the company, often with a combination of a strategic partnership. Xlife Sciences AG offers its investors direct access to the further development of innovative and futureoriented technologies at a very early stage. *

	Start	2019-11-04 existent
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Baumann, Oliver R. (Xlife Sciences 202103 CEO)
	Person 2	Scholz, Bernhard (Xlife Sciences 202201 Board Chair)

	Region	Zürich ZH
	Country	Switzerland
	Street	35 Talacker
	City	8001 Zürich ZH
	Tel	+41-44-385-8460
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Indivumed GmbH. (3/18/21). "Press Release: Indivumed Announces Expansion into Drug Development, Formation of Ix Therapeutics. Joint Venture with Xlife Sciences". Hamburg.

		Record changed: 2023-10-31